Australia, Aug. 28 -- IMUNEXUS THERAPEUTICS Ltd., owns the trademark (2618797) for 'IMUNEXIN' till Jan. 19, 2036.
Status: registered:
Registered/protected
Class: 5 [antitumour drugs; biochemical drugs; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for medical use; chemical preparations containing enzymes for pharmaceutical purposes; chemical products for pharmaceutical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents that facilitate the delivery of pharmaceutical preparations; drugs for medical purposes; drugs for medical use; enzyme preparations for medical purposes; enzymes for medical purpose...